feed,title,long_url,short_url
Benzinga,Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic Stress Disorder,https://benzinga.com/general/biotech/24/01/36485690/silo-pharma-concludes-first-phase-of-dose-ranging-study-of-intranasal-treatment-for-post-traumati,https://da.gd/NKTbe
